Developing digital therapeutics with KYAN Technologies' Prof. Dean Ho
Description
Prof. Dean Ho is the Provost’s Chair Professor and Head of the Department of Biomedical Engineering at the National University of Singapore. He is also the Director of the Institute for Digital Medicine (WisDM) and The N.1 Institute for Health, and one of the Scientific Co-Founders of KYAN Technologies. In this episode, Prof. Ho discusses the importance of accessibility and community in fostering innovation. He highlights the role of academia in bridging the gap between innovation and real-world impact. Prof. Ho also shares his experience in setting up a biotech company in both the US and Singapore, emphasizing the ease and agility of the Singaporean ecosystem. He discusses the opportunities for AI in healthcare, particularly in clinical trial design and digital therapeutics. Prof. Ho also mentions the importance of a human talent pipeline to support the growing biotech industry in Singapore.
Host: John Joson Ng
Editors: Jessie Wong, John Joson Ng
The show notes and transcripts for the episode can be found on nucleatesingapore.substack.com. For feedback or recommendations on who we should talk to next, please reach out to Joson Ng via johnjoson.n@nucleate.xyz.
01:27 Introduction
06:32 The importance of impact
09:53 Singapore’s advantages as an ecosystem
21:36 CURATE.AI, Optim.AI, and other AI technologies
29:39 Digital therapeutics (DTx)
35:56 Growing the local talent pipeline for the biotech industry
42:55 Resources for those interested in biotech
United States
